Medical device and med-tech
First-to-market launches, HCP targeting and DTC demand. Axonics, ONWARD, Inspire, Impulse Dynamics, Laborie, Neuraxis, RECOR.
An agency within an agency.
Healthcare and med-tech marketing built for complex customer journeys, real compliance and measurable growth. The full power of a senior agency, focused on health.
Why MB Health
Healthcare marketing that respects the stakes.
Health decisions are personal, regulated, and rarely linear. MB Health pairs Media Bridge's full-service firepower, strategy, media, creative and data, with healthcare fluency: HIPAA-aware practices, compliance-ready creative, and an understanding of how patients, caregivers and clinicians actually move.
“Whether our budget is $60K or $6 million, we know MB Health will deliver a plan that makes the most of our resources. And achieves our goals.” Heather Hermandson, Inspire Sleep
We run both HCP campaigns, aimed at healthcare professionals, and DTC campaigns, aimed directly at patients, from first-to-market device launches to enrollment and awareness.
- HIPAA-aware practices across every channel and every vendor.
- Compliance-ready creative that survives regulatory review.
- HCP and DTC in one plan, not two disconnected programs.
- Complex customer journeys, mapped to how care actually happens.
- Med-device launches, including first-to-market.
$24.3M
DTC sales attributed for Axonics, with a 97% jump in device implants.
166%
lift in sales for Laborie's Optilume omnichannel launch.
3×
above healthcare industry benchmarks for Impulse Dynamics, at a 57% lower cost per click than industry standards.
Who we serve
Across the health ecosystem.
Providers and health systems
Service-line growth, patient acquisition and reputation. Twin Cities Orthopedics, Allina, Delta Dental.
Payers and consumer health
Member growth, education and trust across complex, regulated journeys where every claim is reviewed.
The MedTech growth blueprint
We know how to fuel MedTech brands from early revenue to market dominance.
Two neuromodulation leaders we helped scale, from launch to landmark exit.
First to market → national leader
A first-to-market neuromodulation implant for obstructive sleep apnea. Ten years of partnership building the mass-awareness and patient-acquisition engine behind it, and the market value climbed year after year.
- Ten years
- $8M to $900M in revenue across the partnership.
- TV test
- 10× higher lift in test markets than in markets without.
- Reach
- Beat the 50% reach goal, and the client added six new markets.
- 2023
- 84% year-over-year revenue growth.
$7B+peak valuation
Startup → $3.7B acquisition
A first-to-market SNM device we helped grow through its direct-to-consumer launch and revenue scale, into a Boston Scientific buyout.
- 2019 · FDA
- Rechargeable R20 SNM system cleared.
- 2021 · DTC
- Direct-to-consumer launch at scale.
- 2022 · Growth
- $361M revenue, number one fastest-growing in the Americas.
- 2023 · Scale
- $24.3M in sales attributed to our DTC campaign, and a 97% jump in device implants.
- 2024 · Exit
- Acquired by Boston Scientific.
$3.7Bacquisition by Boston Scientific
Clients and experience
Brands our team has helped move.
First-in-class devices and diagnostics, health systems, payers and Fortune 500 strategics. These are some of the healthcare and med-tech brands the agency and our team have worked on, and they are only a few. Our experience runs well past this list.
The MB Health advisory board
You don't just get an agency.
Established in 2024. Seven industry leaders across devices, life sciences, capital, marketing, communications, quality and regulatory, for high-level clinical validation and strategic oversight. Regulatory, commercialization, capital and category expertise, on call for the work.
Let's connect
Bring us your hardest health challenge.
Launch, growth, compliance, a complicated journey. MB Health is built for it.